Introduction

Healthcare giant The Cigna Group is moving steadily toward completing its stop-loss margin recovery strategy by 2027. The company faced unexpected medical cost pressures in late 2024, especially from high-cost specialty drugs and complex surgical procedures. However, executives now believe the recovery process is progressing as planned.

Incoming CEO Brian Evanko recently shared updates during the Bank of America Global Healthcare Conference. He explained that the company has already completed nearly two-thirds of its pricing recovery efforts. Additionally, Cigna has managed to retain a strong client base despite implementing substantial premium increases.

What Is Stop-Loss Insurance?

Understanding the Coverage Model

Stop-loss insurance protects self-funded employers from catastrophic healthcare claims. Employers often use this coverage to reduce financial risks linked to expensive treatments and unexpected medical events.

When employee healthcare costs exceed a certain threshold, the stop-loss insurer covers the remaining expenses. Consequently, this insurance model has become critical for many large and mid-sized employers.

Why Demand Is Rising

Healthcare costs continue to climb across the United States. Specialty medications, cancer treatments, and cardiac procedures now create significant financial burdens for employers. Therefore, many organizations increasingly rely on stop-loss protection to manage risk effectively.

Cigna’s Margin Recovery Strategy

2027 Marks the Final Recovery Phase

Brian Evanko stated that 2027 will represent the final year of Cigna’s stop-loss margin recovery initiative. The company introduced major pricing adjustments throughout 2026 to offset higher medical expenses.

According to executives, the repricing strategy is already delivering positive results. Moreover, the company believes its corrective measures will fully restore profitability within the expected timeline.

Strong Client Retention Despite Price Increases

One major concern for insurers during repricing efforts is customer retention. However, Cigna executives noted that employers largely remained loyal despite historically high premium hikes.

This strong retention rate demonstrates confidence in Cigna’s services and underwriting capabilities. Furthermore, it suggests that many employers recognize rising healthcare costs as an industry-wide challenge rather than a company-specific issue.

Stop-Loss Premium Growth Continues

Cigna’s stop-loss business remains one of the largest globally. The company reported approximately $2.1 billion in stop-loss premiums during the first quarter of 2026, compared to nearly $1.9 billion during the same period in 2025. Annual stop-loss premiums now approach $8 billion.

Why Stop-Loss Costs Increased

Specialty Drug Expenses Surged

The company first disclosed major cost pressures in early 2025. Rising utilization of specialty drugs such as Keytruda and Ocrevus significantly increased claim expenses.

These medications often cost thousands of dollars per patient every month. As utilization expanded rapidly, insurers struggled to predict the financial impact accurately.

High-Acuity Surgeries Added Pressure

In addition to drug costs, Cigna also experienced higher spending on oncology and cardiac surgeries. These complex procedures contributed heavily to claim volatility within the stop-loss portfolio.

Unfortunately, many of these cost increases accelerated late in 2024. By that time, much of the 2025 pricing structure had already been finalized. As a result, the company could not immediately adjust premiums to match the changing medical trend.

Incoming CEO Brian Evanko’s Outlook

Leadership Transition Comes at Critical Time

Brian Evanko is scheduled to succeed David Cordani as CEO on July 1. Industry analysts are closely watching how the leadership transition could influence Cigna’s long-term strategy.

Evanko emphasized that healthcare costs remain unsustainable across the industry. Nevertheless, he expressed confidence in the company’s diversified business model and ongoing pricing discipline.

Long-Term Market Stability Expected

Executives believe stop-loss pricing may begin stabilizing after 2027. The company expects future medical trend assumptions to better align with pricing models moving forward.

Additionally, competitors across the stop-loss market are implementing similar corrective measures. Therefore, broader market stabilization may occur over the next several years.

Impact on Employers and Healthcare Markets

Employers Face Higher Premiums

Employers purchasing stop-loss insurance may continue experiencing elevated renewal costs through 2027. However, industry experts believe these increases are necessary to reflect actual medical utilization trends.

Although premium hikes create short-term financial pressure, they also help insurers maintain market stability and long-term coverage availability.

Healthcare Cost Trends Remain a Concern

Specialty pharmacy spending continues to reshape the insurance landscape. Furthermore, higher demand for advanced medical procedures is placing additional pressure on payers and employers alike.

As healthcare utilization rises, insurers will likely continue refining underwriting models, pricing strategies, and cost management initiatives.

Future of the Stop-Loss Insurance Industry

Growth Opportunities Continue

Despite recent challenges, the stop-loss insurance market continues expanding rapidly. Employers increasingly prefer self-funded health plans because they offer flexibility and potential cost savings.

Consequently, insurers view stop-loss coverage as a major growth opportunity within the commercial healthcare market.

Technology and Analytics Will Play Larger Roles

Insurers are also investing heavily in predictive analytics and artificial intelligence tools. These technologies may improve claims forecasting, underwriting accuracy, and risk management over time.

As data capabilities improve, insurers could identify emerging medical cost trends much earlier than before.

Conclusion

Cigna’s stop-loss margin recovery plan appears firmly on track for completion by 2027. The company has implemented aggressive pricing actions while maintaining strong customer retention levels. Additionally, executives remain optimistic about future market stabilization.

Although healthcare costs continue rising, Cigna’s recovery strategy highlights how insurers are adapting to a rapidly changing healthcare environment. The coming years will likely shape the future direction of stop-loss insurance and employer-sponsored healthcare coverage across the industry.